Cipla USA is recalling the affected lot due to "short fill" whereas Glenmark Pharma is recalling 3,264 bottles of Diltiazem Hydrochloride extended-release capsules indicated for high blood pressure, USFDA said.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/mCjOouv
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment